Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Neutral lipid storage disease with myopathy

Triglyceride storage disease with myopathy is an autosomal recessive disorder caused by mutations of the PNPLA2 gene.

Systematic

Neutral lipid storage disease
Neutral lipid storage disease with ichtiosis
Neutral lipid storage disease with myopathy
PNPLA2

References:

1.

Fischer J et al. (2007) The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy.

external link
2.

Akiyama M et al. (2007) Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy.

external link
3.

Reilich P et al. (2011) The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.

external link
4.

Lin P et al. (2012) Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy.

external link
5.

Janssen MC et al. (2013) Symptomatic lipid storage in carriers for the PNPLA2 gene.

external link
6.

OMIM.ORG article

Omim 610717 external link
7.

Orphanet article

Orphanet ID 98908 external link
Update: Aug. 14, 2020
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits